URGN
Biotechnology · Healthcare
CEO
Equibles does not estimate personal net worth.
Get an email with a short summary when UroGen Pharma Ltd. publishes a filing, an earnings call transcript or a press release.
Get URGN alertsLiz Barrett is recorded as CEO at UroGen Pharma Ltd. (URGN). Liz Barrett has spoken on 19 earnings calls and 3 other investor events across 1 company, most recently for UroGen Pharma Ltd. on September 15, 2026. UroGen Pharma Ltd. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at UroGen Pharma Ltd. includes Elizabeth Barrett (CEO and Board Member), Arie Belldegrun (Chairman and Board Member), Chris Degnan (CFO) and 7 others.
“So maybe, you know, I like to start off every fireside by just recapping the company a bit, the key priorities and what investors should should think about um about urogen if they're not familiar with the story or up to speed yes um i think the we have to take a two minute you know back going going back our company…”
“Most people, I think, know about Urogen and how Urogen came to be, but for those that don't, our company was founded on the basis of a proprietary technology called RT-Gel.”
“More importantly, the commercial trends underlying that growth continue to strengthen.”
“Sure I'm actually gonna ask Mark to talk about the technology and and then I'll come back on the market size.”
“Before I provide our business update, I wanted to share that given the critical importance of a successful sister relaunch, the board and I made the decision a few months ago that I would assume direct oversight of the commercial organization, resulting in the departure of David Lynn.”
URGN
Biotechnology · Healthcare
CEO